SELLAS Life Sciences Group, Inc. Income (Loss) from Continuing Operations, Per Basic Share
SELLAS Life Sciences Group, Inc. (SLS) reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.15 per share for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2017-11-09
- SELLAS Life Sciences Group, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2017-09-30 was -$0.15.
- SELLAS Life Sciences Group, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2017-06-30 was -$0.19, a 120.88% decline year-over-year.
- SELLAS Life Sciences Group, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2016-09-30 was -$0.41.
- SELLAS Life Sciences Group, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2016-06-30 was $0.91.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 9 month |
|---|---|---|---|---|---|
| 2017-09-30 | -$0.15 10-Q · filed 2017-11-09 | -$0.45 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | -$0.19 10-Q · filed 2017-08-14 | -$0.29 10-Q · filed 2017-08-14 | |||
| 2016-09-30 | -$0.41 10-Q · filed 2017-11-09 | -$0.97 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | $0.91 10-Q · filed 2017-08-14 | -$0.13 10-Q · filed 2017-08-14 | |||
| 2013-06-30 | -$0.11 10-Q · filed 2013-08-09 | -$0.23 10-Q · filed 2013-08-09 | |||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.01 10-Q · filed 2012-08-14 | -$0.41 10-Q · filed 2013-08-09 | -$0.42 10-Q · filed 2012-08-14 | |
| 2011-06-30 | -$0.04 10-Q · filed 2012-08-14 | -$0.12 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |